Delineating Alzheimers disease progression with MGAT3, a biomarker for improved prognosis and personalized therapy

Biomarkers in Medicine

Volumn 5, Issue 5, 2011, Pages 645-647

  Fiala, Milan ^a   Porter, Verna ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of California ^*  (United States)

Author keywords

Alzheimers disease; bisdemethoxycurcumin; MGAT3 biomarker; vitamin D3

Indexed keywords

ACETYLSALICYLIC ACID; AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; BIOLOGICAL MARKER; COLECALCIFEROL; CURCUMINOID DERIVATIVE; DONEPEZIL; MEMANTINE; MESSENGER RNA; NOOTROPIC AGENT; PROTEIN MGAT3; UNCLASSIFIED DRUG; BETA 1,4 MANNOSYL GLYCOPROTEIN BETA 1,4 N ACETYLGLUCOSAMINYLTRANSFERASE; BETA-1,4-MANNOSYL-GLYCOPROTEIN BETA-1,4-N-ACETYLGLUCOSAMINYLTRANSFERASE; BIS(4-HYDROXYCINNAMOYL)METHANE; CURCUMIN; DIDEMETHOXYCURCUMIN; DRUG DERIVATIVE; N ACETYLGLUCOSAMINYLTRANSFERASE;

ALZHEIMER DISEASE; BEDTIME DOSAGE; DIET SUPPLEMENTATION; DISEASE CLASSIFICATION; DISEASE COURSE; DYSLIPIDEMIA; EDITORIAL; EPISODIC MEMORY; FLOW CYTOMETRY; FUNCTIONAL FOOD; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LABORATORY TEST; MEMORY DISORDER; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; PERSONALIZED MEDICINE; PHAGOCYTOSIS; PROGNOSIS; PROTEIN DEGRADATION; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION REGULATION; GENETICS; METABOLISM; MONONUCLEAR CELL; PATHOLOGY;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BIOLOGICAL MARKERS; CHOLECALCIFEROL; CURCUMIN; DISEASE PROGRESSION; HUMANS; INDIVIDUALIZED MEDICINE; LEUKOCYTES, MONONUCLEAR; N-ACETYLGLUCOSAMINYLTRANSFERASES; PHAGOCYTOSIS; PROGNOSIS;

EID: 80054817058     PISSN: 17520363     EISSN: 17520371     Source Type: Journal    
DOI: 10.2217/bmm.11.64     Document Type: Editorial

References (15)

1. Fiala M, Mahanian M, Rosenthal M, et al. MGAT3 mRNA: a biomarker for prognosis and therapy of Alzheimers disease by vitamin D and curcuminoids. J. Alzheimers Dis. 25(1), 135-144 (2011).
2. Dubois B, Feldman HH, Jacova C, et al. Research criteria for the diagnosis of Alzheimers disease: revising the NINCDS- ADRDA criteria. Lancet Neurol. 6(8), 734-746 (2007). (Pubitemid 47058377)
3. McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimers disease: recommendations from the National Institute on Aging-Alzheimers Association workgroups on diagnostic guidelines for Alzheimers disease. Alzheimers Dement. 7(3), 263-269 (2011).
4. Ray S, Britschgi M, Herbert C, et al. Classification and prediction of clinical Alzheimers diagnosis based on plasma signaling proteins. Nat. Med. 13(11), 1359-1362 (2007). (Pubitemid 350073592)
5. Avagyan H, Goldenson B, Tse E, et al. Immune blood biomarkers of Alzheimer disease patients. J. Neuroimmunol. 210(1-2), 67-72 (2009).
6. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimers disease. Neurology 43(8), 1467-1472 (1993). (Pubitemid 23230526)
7. Gupta VB, Laws SM, Villemagne VL, et al. Plasma apolipoprotein E and Alzheimer disease risk: the AIBL study of aging. Neurology 76(12), 1091-1098 (2011).
8. Nixon RA, Yang DS. Autophagy failure in Alzheimers disease - locating the primary defect. Neurobiol. Dis. 43(1), 38-45 (2011).
9. Small SA, Kent K, Pierce A, et al. Model-guided microarray implicates the retromer complex in Alzheimers disease. Ann. Neurol. 58(6), 909-919 (2005). (Pubitemid 41746881)
10. Fiala M, Liu PT, Espinosα-Jeffrey A, et al. Innate immunity and transcription of MGAT3 and Toll-like receptors in Alzheimers disease patients are improved by bisdemethoxycurcumin. Proc. Natl Acad. Sci. USA 104(31), 12849-12854 (2007). (Pubitemid 47255243)
11. Fiala M, Liu QN, Sayre J, et al. Cyclooxygenase-2-positive macrophages infiltrate the Alzheimers disease brain and damage the blood-brain barrier. Eur. J. Clin. Invest. 32(5), 360-371 (2002). (Pubitemid 36228397)
12. Simard AR, Soulet D, Gowing G, Julien JP, Rivest S. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimers disease. Neuron 49(4), 489-502 (2006). (Pubitemid 43221886)
13. Zaghi J, Goldenson B, Inayathullah M, et al. Alzheimer disease macrophages shuttle amyloid-b from neurons to vessels, contributing to amyloid angiopathy. Acta Neuropathol. 117(2), 111-124 (2009).
14. Shigeta M, Shibukawa Y, Ihara H, Miyoshi E, Taniguchi N, Gu J. b1,4-N-acetylglucosaminyltransferase III potentiates b1 integrin-mediated neuritogenesis induced by serum deprivation in Neuro2a cells. Glycobiology 16(6), 564-571 (2006). (Pubitemid 43779051)
15. Masoumi A, Goldenson B, Ghirmai S, et al. 1a,25-dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-b clearance by macrophages of Alzheimers disease patients. J. Alzheimers Dis. 17, 703-717 (2009).